GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (OSTO:ALZCUR) » Definitions » Accumulated other comprehensive income (loss)

AlzeCure Pharma AB (OSTO:ALZCUR) Accumulated other comprehensive income (loss) : kr0.00 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is AlzeCure Pharma AB Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. AlzeCure Pharma AB's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2024 was kr0.00 Mil.

AlzeCure Pharma AB Accumulated other comprehensive income (loss) Historical Data

The historical data trend for AlzeCure Pharma AB's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzeCure Pharma AB Accumulated other comprehensive income (loss) Chart

AlzeCure Pharma AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial - - - - -

AlzeCure Pharma AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AlzeCure Pharma AB Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

AlzeCure Pharma AB Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of AlzeCure Pharma AB's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

AlzeCure Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (OSTO:ALZCUR) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
OSTO:MOB OSTO:ERMA OSTO:VIVE XSAT:PMED XSAT:ODI XSAT:DICOT OSTO:NANEXA OSTO:NEWBRY OSTO:KLAR OSTO:RLS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
AC6:Germany
Address
Halsovagen 7, Huddinge, SWE, SE 141 57
Website
https://www.alzecurepharma.se
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.

AlzeCure Pharma AB Headlines

No Headlines